يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"pritelivir"', وقت الاستعلام: 1.54s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
    دورية أكاديمية

    المصدر: Infectious Diseases Meeting Abstracts

    العلاقة: https://scholarlycommons.henryford.com/infectiousdiseases_mtgabstracts/21Test; http://sfxhosted.exlibrisgroup.com/hfhs?sid=EMBASE&issn=23288957&id=doi:10.1093%2Fofid%2Fofab466.1254&atitleTest=Pritelivir+in+Immunocompromised+Patients+with+Mucocutaneous+Acyclovir-Resistant+Herpes+Simplex+Virus-Infections+-+First+Case+Series&stitle=Open+Forum+Infect.+Dis.&title=Open+Forum+Infectious+Diseases&volume=8&issue=SUPPL+1&spage=S620&epage=&aulast=Albrecht&aufirst=Kim+WorkowskiJoerg&auinit=K.W.&aufull=Albrecht+K.W.&coden=&isbn=&pages=S620-&date=2021&auinit1=K&auinitm=W

  4. 4
  5. 5
    تقرير

    المصدر: Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects With Treatment Resistant Herpes Simplex Virus Type 1 or 2

  6. 6
    تقرير

    المصدر: A Double-blind, Single-center, Randomized, Placebo- and Positive-controlled, Parallel-group Trial With a Nested Crossover Part on the Electrocardiographic Effects 100 and 400 mg Pritelivir Per Day in Healthy Subjects: a Thorough QT/QTc Trial

  7. 7
    تقرير

    المصدر: A Single-center, Open-label, 2-period Fixed-sequence Phase I Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Pritelivir

  8. 8
    تقرير

    المؤلفون: Medpace, Inc.

    المصدر: A Randomized, Open Label, Multi-center, Comparative Trial, to Assess the Efficacy and Safety of Pritelivir for the Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects (PRIOH-1)

  9. 9
    تقرير

    المؤلفون: Novella Clinical

    المصدر: A Randomized, Double-blind, Multi-center, Three Arm (Pritelivir, Placebo and Zovirax®) Parallel Group, Comparative Trial to Assess the Efficacy and Safety of Pritelivir 5% w/w Ointment for the Treatment of Recurrent Herpes Labialis in Adults - LipP1

  10. 10
    تقرير

    المؤلفون: FHI 360

    المصدر: A Double-blind Randomized Placebo Controlled Dose-finding Trial to Investigate Different Doses of a New Antiviral Drug in Subjects With Genital HSV Type 2 Infection